FN2 Earnings Intelligence

Medpace Holdings, Inc. earnings overview

Latest Medpace Holdings, Inc. (MEDP) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportMedpace Holdings, Inc. reports Monday, Feb 8, 2027 · After market closeConsensus EPS $4.64 · consensus revenue $722.3M
MEDP FY2026 Q3 · Calendar Q4 2026

Medpace Holdings, Inc.

The Q3 update supports a constructive near-term operating trajectory: strong awards, backlog growth, oncology demand, and improved margins outweighed the caution around cancellations and future costs. The evidence is less complete for the longer term because 2027 guidance was deferred.

EPS surprise+9.0%
Market move-1.3%

Get the MEDP recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.